Proteins conspire to make breast cancer cells resistant to drug treatment
Scientists at Sanford-Burnham provide compelling and conclusive evidence that antiestrogen resistance in breast cancer cells requires interaction between proteins called BCAR1 and BCAR3. The study was published in the Journal of Biological Chemistry. April 18, 2014